Trial intelligence / Profile preview

Naproxen as Adjunct Treatment of Cellulitis

NCT07665476Phase 3Not yet recruiting

Sponsor
Ottawa Hospital Research Institute
Start
Nov 2026
Primary completion
Dec 2030
Countries
1
01

Overview

A Phase 3 trial of naproxen in cellulitis, sponsored by Ottawa Hospital Research Institute. Planned start Nov 2026; status: not yet recruiting.

02

Drugs

naproxen
03

Conditions

cellulitis

Beyond the preview

Go deeper on NCT07665476.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07665476.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call